At a glance
- Originator Nonindustrial source
- Class Antifungals; Cytostatic antibiotics; Heterocyclic compounds; Oxazoles
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cancer; Mycoses
Most Recent Events
- 15 Sep 1998 Profile reviewed
- 15 Sep 1998 No-Development-Reported for Cancer in USA (Unknown route)
- 15 Sep 1998 No-Development-Reported for Mycoses in USA (Unknown route)